This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:anxiety [03.11.2019] – [Anxiety] sallieq | home:diseases:anxiety [08.13.2019] – [Patient interviews] sallieq | ||
---|---|---|---|
Line 10: | Line 10: | ||
Patients suffering from anxiety may wish to modify their dose of antibiotics or take an [[home: | Patients suffering from anxiety may wish to modify their dose of antibiotics or take an [[home: | ||
- | ===== Evidence of infectious cause ===== | ||
- | Mark Lyte of the Texas Tech University School of Pharmacy noticed that lab mice dosed with // | ||
- | |||
- | < | ||
- | |||
- | //**L.E. Goehler** et al.// | ||
- | |||
- | Further, Neufeld //et al.// showed that germ-free mice exhibited reduced anxiety-like behavior as well as significant neurochemical changes in the brain compared to mice without an intestinal microbiota.(({{pubmed> | ||
- | |||
- | |||
- | |||
- | The frequency with which patients of certain Th1 diseases also experience anxiety(({{pubmed> | ||
- | |||
- | |||
- | < | ||
- | It is my opinion that early and prominent symptoms of Th1 disease are psychological which have been interpreted as anxiety, depression, insomnia, learning disabilities etc. These symptoms like physical ones are exacerbated during effective treatment of Th1 [diseases]. | ||
- | |||
- | By understanding this, one can lessen some of the impact of those symptoms, just as one can with the physical symptoms. Not knowing why one is ' | ||
- | |||
- | //**Greg Blaney, MD**// </ | ||
Line 37: | Line 17: | ||
Anxiety can and should be managed just like other symptoms. The following strategies and therapies may limit or help manage the anxiety a patient experiences | Anxiety can and should be managed just like other symptoms. The following strategies and therapies may limit or help manage the anxiety a patient experiences | ||
* Restrict light exposure. It is very common for MP patients to experience anxiety in the hours or days following light exposure. | * Restrict light exposure. It is very common for MP patients to experience anxiety in the hours or days following light exposure. | ||
- | * Modify doses of antibiotics. | + | |
+ | * Go for a walk. | ||
+ | | ||
* Take an [[home: | * Take an [[home: | ||
* Practice good sleep hygiene. | * Practice good sleep hygiene. | ||
- | * Try relaxation techniques. | + | * Learn relaxation techniques. |
* Listen to soothing music. | * Listen to soothing music. | ||
* Try [[home: | * Try [[home: | ||
Line 119: | Line 101: | ||
Interviews of patients with other diseases are [[home: | Interviews of patients with other diseases are [[home: | ||
+ | ===== Evidence of infectious cause ===== | ||
+ | Mark Lyte of the Texas Tech University School of Pharmacy noticed that lab mice dosed with // | ||
+ | < | ||
+ | //**L.E. Goehler** et al.// | ||
+ | Further, Neufeld //et al.// showed that germ-free mice exhibited reduced anxiety-like behavior as well as significant neurochemical changes in the brain compared to specific-pathogen-free mice. (({{pubmed> | ||
+ | The frequency with which patients of certain Th1 diseases also experience anxiety(({{pubmed> | ||
+ | < | ||
+ | It is my opinion that early and prominent symptoms of Th1 disease are psychological which have been interpreted as anxiety, depression, insomnia, learning disabilities etc. These symptoms like physical ones are exacerbated during effective treatment of Th1 [diseases]. | ||
+ | By understanding this, one can lessen some of the impact of those symptoms, just as one can with the physical symptoms. Not knowing why one is ' | ||
- | + | //**Greg Blaney, MD**// </ | |
- | + | ||